Y. Wang, L. Meyerson, Y. Tang, and N. Qian. Journal of the neurological sciences, 285 (1-2):
206-11(October 2009)5489<m:linebreak></m:linebreak>JID: 0375403; 0 (Antibodies, Monoclonal); 0 (Immunologic Factors); 0 (natalizumab); 2009/03/05 received; 2009/07/15 revised; 2009/07/22 accepted; 2009/08/25 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Count data.
B. Calster, Y. Vergouwe, C. Looman, V. Belle, D. Timmerman, and E. Steyerberg. European journal of epidemiology, 27 (10):
761-70(October 2012)7087<br/>JID: 8508062; 2012/05/14 received; 2012/09/14 accepted; 2012/10/07 aheadofprint; ppublish;<br/>Models predictius; Avaluació de riscs.
M. del Águila, and N. Benítez-Parejo. Allergologia et immunopathologia, 39 (3):
159-73(2011)6391<m:linebreak></m:linebreak>CI: Copyright (c) 2011; JID: 0370073; 2011/02/01 received; 2011/02/01 accepted; 2011/05/06 aheadofprint; ppublish;.
R. Daniel, S. Cousens, B. Stavola, M. Kenward, and J. Sterne. Statistics in medicine, 32 (9):
1584-618(April 2013)CI: Copyright (c) 2012; JID: 8215016; 2010/07/22 received; 2012/10/30 accepted; 2012/12/03 aheadofprint; ppublish;<m:linebreak></m:linebreak>Propensity score; Marginal structural models.